Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 2/2017

01-06-2017 | Original Article

Effect of glycaemic control on the diurnal blood pressure variation and endogenous secretory receptor for advanced glycation end product (esRAGE) levels in type 1 diabetes mellitus

Authors: R. Vimalavathini, B. Gitanjali

Published in: International Journal of Diabetes in Developing Countries | Issue 2/2017

Login to get access

Abstract

The relationship between plasma endogenous secretory receptor for advanced glycation end product (esRAGE) level and diurnal variation of blood pressure in type 1 diabetic patients based on their glycemic status has not yet been studied. So, the aim of the present study was to see if a correlation exists between plasma esRAGE levels and dipper status in type 1 diabetic patients based on their glycaemic status. Type 1 diabetic patients were divided as good and poor glycaemic controlled groups based on their HbA1c values. Blood glucose levels, insulin, insulin antibodies, homocysteine and esRAGE levels were determined. The hourly daytime and night-time blood pressure was monitored by using a non-invasive blood pressure (NIBP) apparatus. Of the 16 patients in the well-controlled group, most (14/16) were dippers (95 % confidence interval 1.5 to 20.7 vs. P = 0.006, Fisher’s exact test) when compared to those in the poorly controlled group (5/18). There was a significant correlation between plasma esRAGE levels and % decline in nocturnal blood pressure in both the good (r = 0.69, P = 0.003) and poorly (r = 0.79, P = 0.0002) controlled groups. Most of the poorly controlled patients showed abnormal circadian blood pressure pattern and low esRAGE level and hence were more prone to end organ damage.
Literature
1.
go back to reference Jakus V, Rietbrock N. Advanced glycation end-products and the progress of diabetic vascular complications. Physiol Res. 2004;53(2):131–42.PubMed Jakus V, Rietbrock N. Advanced glycation end-products and the progress of diabetic vascular complications. Physiol Res. 2004;53(2):131–42.PubMed
2.
go back to reference Yonekura H, Yamamoto Y, Sakurai S, Watanabe T, Yamamoto H. Roles of the receptor for advanced glycation end products in diabetes-induced vascular injury. J Pharmacol Sci. 2005;97(3):305–11.CrossRefPubMed Yonekura H, Yamamoto Y, Sakurai S, Watanabe T, Yamamoto H. Roles of the receptor for advanced glycation end products in diabetes-induced vascular injury. J Pharmacol Sci. 2005;97(3):305–11.CrossRefPubMed
3.
go back to reference Birkenhäger AM, van den Meiracker AH. Causes and consequences of a non-dipping blood pressure profile. Neth J Med. 2007;65:127–31.PubMed Birkenhäger AM, van den Meiracker AH. Causes and consequences of a non-dipping blood pressure profile. Neth J Med. 2007;65:127–31.PubMed
4.
go back to reference Gilbert R, Phillips P, Clarke C, Jerums G. Day-night blood pressure variation in normotensive, normoalbuminuric type 1 diabetic subjects: dippers and non-dippers. Diabetes Care. 1994;17:824–7.CrossRefPubMed Gilbert R, Phillips P, Clarke C, Jerums G. Day-night blood pressure variation in normotensive, normoalbuminuric type 1 diabetic subjects: dippers and non-dippers. Diabetes Care. 1994;17:824–7.CrossRefPubMed
5.
go back to reference Hansen HP, Hovind P, Jensen BR, Parving HH. Diurnal variations of glomerular filtration rate and albuminuria in diabetic nephropathy. Kidney Int. 2002;61(1):163–8.CrossRefPubMed Hansen HP, Hovind P, Jensen BR, Parving HH. Diurnal variations of glomerular filtration rate and albuminuria in diabetic nephropathy. Kidney Int. 2002;61(1):163–8.CrossRefPubMed
6.
go back to reference Spallone V, Gambardella S, Maiello MR, Barini A, Frontoni S, Menzinger G. Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients. Diabetes Care. 1994;17:578–84.CrossRefPubMed Spallone V, Gambardella S, Maiello MR, Barini A, Frontoni S, Menzinger G. Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients. Diabetes Care. 1994;17:578–84.CrossRefPubMed
7.
go back to reference American Diabetes Association. Standards of medical care. Diabetes Care. 2006;29 Suppl 1:S4–42. American Diabetes Association. Standards of medical care. Diabetes Care. 2006;29 Suppl 1:S4–42.
8.
go back to reference Heise T, Kawabata T, Bott S, Finco-Kent D, Tusek C, Liu C, et al. The effect of insulin antibodies on the metabolic action of inhaled and subcutaneous insulin. Diabetes Care. 2005;28(9):2161–9.CrossRefPubMed Heise T, Kawabata T, Bott S, Finco-Kent D, Tusek C, Liu C, et al. The effect of insulin antibodies on the metabolic action of inhaled and subcutaneous insulin. Diabetes Care. 2005;28(9):2161–9.CrossRefPubMed
9.
go back to reference Neugebauer S, Tarnow L, Stehouwer C, Teerlink T, Baba T, Watanabe T, et al. Total plasma homocysteine is associated with hypertension in type 1 diabetic patients. Diabetologia. 2002;45:1315–24.CrossRefPubMed Neugebauer S, Tarnow L, Stehouwer C, Teerlink T, Baba T, Watanabe T, et al. Total plasma homocysteine is associated with hypertension in type 1 diabetic patients. Diabetologia. 2002;45:1315–24.CrossRefPubMed
10.
go back to reference Ingelsson E, Sullivan L, Murabito JM, Fox CS, Benjamin EJ, Polak JF, et al. Prevalence and prognostic impact of sub clinical cardiovascular disease in individuals with the metabolic syndrome and diabetes. Diabetes. 2007;56(6):1718–26.CrossRefPubMed Ingelsson E, Sullivan L, Murabito JM, Fox CS, Benjamin EJ, Polak JF, et al. Prevalence and prognostic impact of sub clinical cardiovascular disease in individuals with the metabolic syndrome and diabetes. Diabetes. 2007;56(6):1718–26.CrossRefPubMed
12.
go back to reference Ijiri H, Kohno I, Yin D, Iwasaki H, Takusagawa M, Lida T, et al. Cardiac arrhythmias and left ventricular hypertrophy in dipper and nondipper patients with essential hypertension. Jpn Circ J. 2000;64:499–504.CrossRefPubMed Ijiri H, Kohno I, Yin D, Iwasaki H, Takusagawa M, Lida T, et al. Cardiac arrhythmias and left ventricular hypertrophy in dipper and nondipper patients with essential hypertension. Jpn Circ J. 2000;64:499–504.CrossRefPubMed
13.
go back to reference Cohen CN, Albanesi FM, Goncalves MF, Gomes MB. Microalbuminuria, high blood pressure burden, and nondipper phenomenon. Diabetes Care. 2001;24(4):790–1.CrossRefPubMed Cohen CN, Albanesi FM, Goncalves MF, Gomes MB. Microalbuminuria, high blood pressure burden, and nondipper phenomenon. Diabetes Care. 2001;24(4):790–1.CrossRefPubMed
14.
go back to reference Deepa R, Velmurugan K, Saravanan G, Karkuzhali K, Dwarakanath V, Mohan V. Absence of association between serum homocysteine levels and coronary artery disease in south Indian males. Indian Heart J. 2001;53:44–7.PubMed Deepa R, Velmurugan K, Saravanan G, Karkuzhali K, Dwarakanath V, Mohan V. Absence of association between serum homocysteine levels and coronary artery disease in south Indian males. Indian Heart J. 2001;53:44–7.PubMed
15.
go back to reference Katakami N, Matsuhisa M, Kaneto H, Matsuoka TA, Sakamoto K, Nakatani Y, et al. Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications. Diabetes Care. 2005;28:2716–21.CrossRefPubMed Katakami N, Matsuhisa M, Kaneto H, Matsuoka TA, Sakamoto K, Nakatani Y, et al. Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications. Diabetes Care. 2005;28:2716–21.CrossRefPubMed
16.
go back to reference Leslie RDG, Beyan H, Sawtell P, Boehm BO, Spector TD, Snieder H. Level of an advanced glycated end product is genetically determined: a study of normal twins. Diabetes. 2003;52:2441–4.CrossRefPubMed Leslie RDG, Beyan H, Sawtell P, Boehm BO, Spector TD, Snieder H. Level of an advanced glycated end product is genetically determined: a study of normal twins. Diabetes. 2003;52:2441–4.CrossRefPubMed
17.
go back to reference Spallone V, Maiello MR, Cicconetti E, Pannone A, Barini A, Gambardella S, et al. Factors determining the 24-h blood pressure profile in normotensive patients with type 1 and type 2 diabetes. J Hum Hypertens. 2001;15:239–46.CrossRefPubMed Spallone V, Maiello MR, Cicconetti E, Pannone A, Barini A, Gambardella S, et al. Factors determining the 24-h blood pressure profile in normotensive patients with type 1 and type 2 diabetes. J Hum Hypertens. 2001;15:239–46.CrossRefPubMed
Metadata
Title
Effect of glycaemic control on the diurnal blood pressure variation and endogenous secretory receptor for advanced glycation end product (esRAGE) levels in type 1 diabetes mellitus
Authors
R. Vimalavathini
B. Gitanjali
Publication date
01-06-2017
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 2/2017
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-015-0436-7

Other articles of this Issue 2/2017

International Journal of Diabetes in Developing Countries 2/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.